Lantheus Holdings (LNTH) Enterprise Value (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Enterprise Value came in at -$498.6 million in Q1 2026, up 46.88% year-on-year from -$339.5 million in Q1 2025, and down 38.83% on a QoQ basis from -$359.1 million in Q4 2025.
Lantheus Holdings (LNTH) Enterprise Value (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Enterprise Value data on file, last reported at -$498.6 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 46.88% year-over-year to -$498.6 million in Q1 2026; TTM through Mar 2026 was -$498.6 million, a 46.88% increase from a year earlier, with the FY2025 full-year figure at -$359.1 million, up 60.66% from the prior year.
- Enterprise Value for Q1 2026 stood at -$498.6 million, down from -$359.1 million in the prior quarter.
- Over the last five years, Enterprise Value for LNTH reached as high as -$105.4 million in Q1 2022 and fell as low as -$938.5 million in Q1 2025.
- Historically, Enterprise Value has averaged -$546.5 million across 5 years, with a median of -$498.6 million in 2026.
- Across the five-year window, Enterprise Value tumbled 346.93% in 2023 and jumped 60.66% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$415.7 million in 2022, then slumped by 71.7% to -$713.7 million in 2023, then decreased by 27.91% to -$912.8 million in 2024, then soared by 60.66% to -$359.1 million in 2025, then slumped by 38.83% to -$498.6 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$498.6 million in Q1 2026, -$359.1 million in Q4 2025, and -$382.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | -498.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -498.58 Mn |
| Dec 31, 2025 | -359.12 Mn |
| Sep 30, 2025 | -382.01 Mn |
| Jun 30, 2025 | -695.57 Mn |
| Mar 31, 2025 | -938.53 Mn |
| Dec 31, 2024 | -912.81 Mn |
| Sep 30, 2024 | -866.39 Mn |
| Jun 30, 2024 | -757.02 Mn |
| Mar 31, 2024 | -718.28 Mn |
| Dec 31, 2023 | -713.66 Mn |
| Sep 30, 2023 | -614.13 Mn |
| Jun 30, 2023 | -414.08 Mn |
| Mar 31, 2023 | -470.86 Mn |
| Dec 31, 2022 | -415.65 Mn |
| Sep 30, 2022 | -257.26 Mn |
| Jun 30, 2022 | -171.43 Mn |
| Mar 31, 2022 | -105.36 Mn |
| Dec 31, 2021 | -98.51 Mn |
| Sep 30, 2021 | -91.48 Mn |
| Jun 30, 2021 | -91.50 Mn |